Large-scale testing (Phase 3)Active Not RecruitingNCT03233711
What this trial is testing
Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Who this might be right for
Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal Margin Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI) 344